DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The South Carolina inmate chose the method because of his concerns about lethal injection, his lawyer said. By Eduardo Medina Reporting from Columbia, S.C. The state of South Carolina executed a ...

“The fact that he ‘chose’ this, that tells you how fearful he is about this lethal injection process that’s so shrouded in secrecy,” his lawyer, Gerald “Bo” King, told the Washington Pos ...

“The fact that he ‘chose’ this, that tells you how fearful he is about this lethal injection process that’s so shrouded in secrecy,” his lawyer, Gerald “Bo” King, told the Washington Post. Sigmon ...

which is administered as an IV bolus followed by a 60-minute infusion. Genentech will also be introducing a new 25 mg vial configuration in the coming months to support the approval of TNKase for AIS.

The FDA approved a one-time, five-minute IV bolus infusion of tenecteplase for adults with acute ischemic stroke. Image: Adobe Stock "The approval of TNKase represents a meaningful advancement in ...

The Abu Dhabi royal sometimes called “the spy sheikh” is accustomed to using his vast wealth to master his many obsessions, which have ranged over the years from martial arts to chess to ...